ABVX(ABVX)
ABVX
ANALYST COVERAGE9 analysts
BUY
▲ +16.4%upside to target
L $110.00
Med $142.00consensus
H $175.00Key MetricsTTM
Market Cap$8.40B
Revenue TTM—
Net Income TTM—
Free Cash Flow—
Gross Margin—
Operating Margin—
Net Margin—
Return on Equity-165.2%
Return on Assets—
Debt / Equity0.07
Current Ratio8.75
EPS TTM$-4.83
PRICE
Prev Close
124.03
Open
125.00
Day Range120.05 – 125.47
120.05
125.47
52W Range5.59 – 148.83
5.59
148.83
81% of range
VOLUME & SIZE
Avg Volume
966.9K
FUNDAMENTALS
P/E Ratio
-21.8x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
67
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 100 days
Aug 31
ABVX News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Country
France
Website
Kevin ShanVice President & Global Head of Biometrics
Marc de GaridelChief Executive Officer & Director
Chris RabbatVice President & Global Head of Medical Affairs
Douglas JacobsteinSenior VP & Global Head of Clinical Development
Nadege Briancon-ErisSenior VP & Global Head of Program Management
Ida HatoumChief People & Compliance Officer
Hema KeshavaSenior Vice President of Finance
Mary MantockSenior VP & Global Head of Regulatory Affairs
Didier BlondelEVice President, Chief Financial Officer & Board Secretary
Didier ScherrerChief Scientific Officer
Jerome DenisExecutive Vice President of Process Development & Manufacturing
Patrick MalloySenior Vice President of Investor Relations
Pierre CourteilleChief Business Officer